Frontlight ResearchEarly access
Taking peopleNo phase
Population Pharmacokinetic of Piperacillin/Tazobactam in Maternal and Neonatal Populations
Key facts
- Who runs it
- Shandong University
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 50 people, planned
- Started
- 30 Sept 2023
- Expected to end
- 31 Dec 2026
- Type of study
- Observational
- Treatments tested
- Piperacillin Sodium and Tazobactam Sodium for Injection
- Record updated
- 10 October 2023
Who can take part
- Age
- 18 years and older
- Sex
- Women only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Patients over 18 years old
- Pregnant women whose baby are at high risk of developing early-onset sepsis after birth have indications to use preventive or therapeutic antibiotics, and the antibiotics used are PIP/TAZO;
- Patients and their families are fully aware of the research content and sign the informed consent form
Who cannot take part
- Receiving other systemic trial drugs
- Intolerance or serious adverse reactions to antibiotic use
- Patients who stopped using PIP/TAZO more than 24 hours before delivery
- There are other factors that the researchers think are not suitable for inclusion
This trial is currently available in China.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The purpose of this study is to describe the population pharmacokinetic characteristics of piperacillin/tazobactam after intravenous administration in pregnant women during pregnancy and delivery, and to evaluate pharmacodynamic effectiveness and safety of piperacillin/tazobactam in pregnant women whose baby are at high risk of developing early-onset sepsis after birth.
Treatments tested
- Piperacillin Sodium and Tazobactam Sodium for Injection
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Population Pharmacokinetic of Piperacillin/Tazobactam in Maternal and Neonatal Populations With High Risk for EOS
- Record updated
- 10 October 2023